Project Grant K08CA293255
Award Date
9/1/24
Completion Date
8/31/29
Dollars Obligated
$217K
Federal Agency
National Cancer Institute
Federal Grant Program
93.398
Assistance Type
Project Grant
Place of Performance
Nashville, TN 37203, USA
Similar Awards
This $1,465,026 Project Grant awarded by the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research (CFDA 93.121) program aims to leverage artificial intelligence and computational imaging to improve diagnosis and treatment of lymphedema and fibrosis in head and neck cancer patients. The project, titled "Harvard MD Anderson Collaborative to Reduce Lymphatic Morbidity in Head and Neck Cancer with Artificial Intelligence...
This Cooperative Agreement award from the Department of Health and Human Services' Advanced Research Projects Agency for Health (ARPA-H) program, CFDA 93.384, provides $8,874,227 to the University of Washington to develop a suite of technologies to enable surgeons to more completely and accurately remove solid tumors. The goal is to improve patient outcomes by reducing the need for additional surgeries. The technologies will initially be developed and validated for breast and head and neck...
The National Cancer Institute (NCI) awarded a $403,383 Project Grant (CFDA 93.395 - Cancer Treatment Research) to the Medstar Health Research Institute Inc. to develop and pilot test a new virtual reality (VR) therapy that integrates cognitive behavioral therapy (CBT) strategies for managing chronic cancer pain. The goal is to create an evidence-based, patient-centered VR prototype ("VR-CAN") through focus groups, provider interviews, and usability testing, and then conduct a...
The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded a $695,814 Project Grant under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to Mayo Clinic Arizona. The project aims to develop advanced artificial intelligence (AI) tools to enable online adaptive proton therapy for treating head and neck cancers. Key objectives include AI-powered synthesis of 3D CT images from 2D X-ray images, real-time deformable...
This federal Cooperative Agreement award, issued by the Department of the Interior's Interior Business Center under the Advanced Research Projects Agency for Health (ARPA-H) program (CFDA 93.384), supports the development of a novel imaging technology called "VISION" that enables real-time, high-resolution intraoperative detection of microscopic residual cancer cells during surgical procedures. The $5,160,920 award to the Regents of the University of California, San Francisco aims to...
This Project Grant award from the National Cancer Institute (CFDA 93.394 - Cancer Detection and Diagnosis Research) to Yale University totals $167,500 and will be executed from September 2023 through August 2025. The primary objectives are to: Develop deep neural network-based emulation analysis methods and software to objectively quantify the relative effectiveness of drugs, devices, and treatment procedures on cancer prognosis, especially when randomized clinical trials are not feasible. The...
This Cooperative Agreement, awarded by the Department of the Interior's Interior Business Center under the Advanced Research Projects Agency for Health (ARPA-H) program (CFDA 93.384), provides $8,945,662.00 in funding to Emory University to develop a functional prototype system called "MARGINCALL" that can rapidly image surgical specimen contours, mark resection margins, and use AI to map cancer and assess tumor proximity to margins. The goal is to reduce current rates of lumpectomy...
This $381,100 Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) supports the development and evaluation of tumor-targeting polymeric micelles carrying a near-infrared (NIR) imaging agent. The goal is to provide real-time optical image guidance during brain cancer surgery to improve tumor resection and surgical outcomes. The project aims to: 1) develop and characterize the tumor-targeting polymeric...
This federal Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), is funding the development and validation of a wide-field fluorescence lifetime imaging (FLT) system for intraoperative sarcoma surgeries. The $567,340 award, effective January 15, 2025 through December 31, 2028, supports a collaboration between the Massachusetts Eye and...
This $300,000 Project Grant awarded by the National Science Foundation (NSF) under the Integrative Activities (CFDA 47.083) program supports the development of an innovative, intelligent surgical probe for prostate cancer treatment. The project aims to create an edge artificial intelligence (AI) system-on-chip for bioimpedance analysis that can accurately distinguish cancerous from healthy tissue during prostate removal surgery. The novel technology being developed includes an adaptive filter to...